SCHIZO AFFECTIVE DISORDER
Clinical trials for SCHIZO AFFECTIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new SCHIZO AFFECTIVE DISORDER trials appear
Sign up with your email to follow new studies for SCHIZO AFFECTIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Mayo clinic tailors weight loss drugs to your brain and gut
Disease control Recruiting nowThis study aims to find the best weight loss medication for people with bipolar disorder by first identifying their specific eating patterns, like 'emotional hunger' or 'hungry gut.' Researchers will match 100 participants to one of three FDA-approved weight loss drugs or a no-me…
Matched conditions: SCHIZO AFFECTIVE DISORDER
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Gentler brain zap shows promise for suicidal thoughts without memory loss
Disease control Recruiting nowThis study tests whether a new, lower-power version of electroconvulsive therapy (ECT) works better for reducing suicidal thoughts than standard ECT. Researchers will compare both treatments in 30 adults with severe depression, bipolar disorder, or related conditions who have sui…
Matched conditions: SCHIZO AFFECTIVE DISORDER
Phase: PHASE2, PHASE3 • Sponsor: Michigan State University • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Zapping the brain to read faces: new hope for schizophrenia social skills
Disease control Recruiting nowThis study is testing whether a gentle, non-invasive brain stimulation technique can help people with schizophrenia better recognize emotions on people's faces. Researchers will use brain scans and other tests to see if stimulating a specific motion-processing area improves this …
Matched conditions: SCHIZO AFFECTIVE DISORDER
Phase: NA • Sponsor: Nathan Kline Institute for Psychiatric Research • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Old allergy drug gets new shot at easing schizophrenia
Symptom relief Recruiting nowThis study is testing if adding a repurposed allergy/asthma drug called cromoglicate to standard antipsychotic medication can help reduce symptoms in adults with schizophrenia or schizoaffective disorder. It will enroll 160 outpatients who are still experiencing significant sympt…
Matched conditions: SCHIZO AFFECTIVE DISORDER
Phase: PHASE1, PHASE2 • Sponsor: Vishwajit Nimgaonkar, MD PhD • Aim: Symptom relief
Last updated Mar 31, 2026 12:12 UTC
-
Scientists search for Brain's early warning signs of psychosis
Knowledge-focused Recruiting nowThis study aims to find new brain-based markers for psychosis by measuring visual processing in people with schizophrenia, bipolar disorder, and healthy controls. Researchers will use EEG (electroencephalography) to record brain waves while participants view images. The goal is t…
Matched conditions: SCHIZO AFFECTIVE DISORDER
Phase: NA • Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC
-
Scientists map the Brain's hallucination highway
Knowledge-focused Recruiting nowThis study aims to understand the brain circuits involved in hallucinations experienced by people with schizophrenia. Researchers will use a non-invasive magnetic stimulation technique (TMS) and brain scans (MRI) on 68 participants to measure how specific brain connections change…
Matched conditions: SCHIZO AFFECTIVE DISORDER
Phase: NA • Sponsor: Mclean Hospital • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC